Head to Head Comparison: Guardian Pharmacy Services (NYSE:GRDN) vs. Todos Med (OTCMKTS:TOMDF)

Todos Med (OTCMKTS:TOMDF) and Guardian Pharmacy Services (NYSE:GRDN) are both healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, analyst recommendations, valuation, profitability, earnings and risk.

Earnings and Valuation

This table compares Todos Med and Guardian Pharmacy Services”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Todos Med	N/A	N/A	N/A	N/A	N/A
Guardian Pharmacy Services	$1.45 billion	1.35	$49.22 million	$1.03	38.20

Guardian Pharmacy Services has higher revenue and earnings than Todos Med.

Volatility and Risk

Todos Med has a beta of -0.01, indicating that its stock price is 101% less volatile than the S&P 500. Comparatively, Guardian Pharmacy Services has a beta of 0.11, indicating that its stock price is 89% less volatile than the S&P 500.

Analyst Ratings

This is a summary of current ratings and price targets for Todos Med and Guardian Pharmacy Services, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Todos Med	0	0	0	0	0.00
Guardian Pharmacy Services	0	2	7	0	2.78

Guardian Pharmacy Services has a consensus target price of $43.83, suggesting a potential upside of 11.39%. Given Guardian Pharmacy Services’ stronger consensus rating and higher probable upside, analysts clearly believe Guardian Pharmacy Services is more favorable than Todos Med.

Profitability

This table compares Todos Med and Guardian Pharmacy Services’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Todos Med	N/A	N/A	N/A
Guardian Pharmacy Services	4.50%	29.97%	16.18%

Summary

Guardian Pharmacy Services beats Todos Med on 8 of the 8 factors compared between the two stocks.

About Todos Med

Todos Medical Ltd., a vitro diagnostics company, develops and commercializes blood tests for the detection of cancer and Alzheimer disease in the United States. The company develops Total Biochemical Infrared Analysis, a proprietary cancer-screening technology using peripheral blood spectroscopy analysis for examination into cancer's influence on the immune system; Lymphocyte Proliferation Test, a diagnostic blood test that determines the ability of peripheral blood lymphocytes and monocytes to withstand an exogenous mitogenic stimulation that induces them to enter the cell cycle; and blood tests for the detection of neurodegenerative disorders, such as Alzheimer's disease. Its cancer screening and diagnosis products include TM-B1 and TM-B2 for breast cancer tests; and TMC blood test for the screening and diagnosis of colon cancer. The company also offers Tollovid, a 3CL protease inhibitor dietary supplement to support healthy immune function against circulating coronaviruses; and Tollovir, an antiviral treatment for Covid-19 that is in Phase 2 clinical trial. Todos Medical Ltd. has a collaboration agreement with Integrated Health LLC, as well as has agreements with various companies to develop screening tests for SARS-nCoV-2; and to distribute certain COVID-19 test kits. Todos Medical Ltd. was incorporated in 2010 and is headquartered in Tel Aviv, Israel.

About Guardian Pharmacy Services

Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company’s Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs. The company was founded in 2003 and is based in Atlanta, Georgia.